This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond.
The discussion covered key aspects from the live Questions asked by the participants on the topic of oral liquid dosage form manufacturing. The panel also explored vendor qualification for secondary packaging materials and trend analysis in water testing as critical elements of maintaining high-quality oral liquid production standards.
As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.
The new facility will feature state-of-the-art cleanroom packaging and high-sensitivity analytical testing capabilities. Communication between the manufacturing plant and retail stores. as part of the company’s commitment to providing a reliable supply of bioprocessing ingredients and excipients to the biopharma and pharmaceutical industries.
The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.
Bhakti Halkude, associate director and head of drug product at Continuus who focuses on oral solid dosage, contends that what is needed in the industry is a major shift — both ideologically and technologically — driven by the need for greater efficiency, cost reduction, and improved product quality.
Recent Videos Related Content BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. PharmTech.com , May 8, 2025.
“CDMOs may follow organic or inorganic growth strategies when considering to either enhance their services on specific products, with the aim of becoming a ‘one-stop shop’ for a specific dosage form, or to diversify their lines of business and potentially reach more customers,” the report said.
More than 30,000 patients have been treated with CAR T cell therapies, with studies including an analysis of BMS presented recently showing that most serious adverse events occur within the first two weeks of infusion. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.
Tjoapack Announces Packaging, Cold Chain Expansions in US and Netherlands Patrick Lavery June 9th 2025 Article Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification before the fourth quarter of 2025.
In such event, Sponsor reserves the right to award the prizes at random from among the eligible entries received up to the time of the impairment. In no event will more than one Prize be awarded.
Recent Videos Related Content BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. Press Release. June 12, 2025.
BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing.
Bristol Myers Squibb Application for Psoriatic Arthritis Drug Accepted for Review in Four Regions Patrick Lavery July 22nd 2025 Article Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.
Organized by the Conference Forum, the event brings together pharmaceutical developers, biotech innovators, and drug delivery specialists to examine advances in the formulation, design, and commercial deployment of therapeutics across a range of modalities (1).
With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Unveiling excellence in pharma Day 1 of the event showcased the Pharma Connect Congress, which addressed pivotal themes shaping the pharmaceutical landscape.
Stage 1: design the compounding blueprint Establish a complete plan including ingredients, packaging, calculations, labeling, and patient-specific factors. Stage 3: dosage form completion & quality evaluation Conduct rigorous physical and analytical testing; 503B batches must meet GMP-level standards. antineoplastics, allergens).
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review Diana Russo July 4th 2025 Article Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles.
9 Implications of Trump’s Tax-Cut and Spending Bill for the Bio/Pharmaceutical Industry Christopher Cole July 7th 2025 Article Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting strategy across the bio/pharmaceutical industry.
New Company Chrysalis Launches After Acquisition of Cleanroom Assets Patrick Lavery June 17th 2025 Article Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.
CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging.
CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. This year’s event marks the 20th anniversary of the CPHI Pharma Awards.
West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.
West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.
West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.
The event attracted over 200 attendees and continued the PULSE series’ role in providing a platform for industry learning. Bhatkar covered the requirements for sterile dosage manufacturing and the coordination between actuation and architectural design. The session began with a keynote address by Thiru M.
The ADAPTA 50 capsule filler features innovative technical solutions to manage complex solid dosage forms such as product combination in hard gelatine capsules or powder micro-dosing for Dry Powder Inhalers. customers will have the opportunity to experience first hand various digital solutions aimed at reducing maintenance costs and downtime.
CPHI is a global platform that unites over 100,000 professionals from the pharmaceutical industry, hosting events in Spain, North America, the Middle East, India, Southeast Asia, Japan, and Korea. The team’s main goal at the event was to meet local medical companies in advance and explore their needs.
Counterfeit drugs, intentionally mislabeled or misrepresented, often contain substandard or harmful ingredients, incorrect dosages, or no active ingredients at all. The introduction of track and trace systems, facilitated by unique identification codes on drug packaging, has played a vital role in multiple ways.
BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing. BASF Opens GMP Manufacturing Facility in Michigan Susan Haigney June 19th 2025 Article The new facility offers cleanroom packaging and high-sensitivity analytical testing.
Introduction Medication error is any preventable event that may harm patient. Also, similar packaging design across medication strengths can lead to inadvertent selection errors, potentially impacting patient safety. This highlights the importance of double-checking unfamiliar dosages to prevent potentially serious medication errors.
Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).
Starting materials are processed, sampled, tested, packaged, and released before the finished products are stacked on pharmacy shelves. Sampling is carried out on intermediate processed materials and tested to ensure those are formulated correctly, free from contamination and qualified for filling and packaging. as their visual aids.
These events led to the publication of the EU Pharmaceuticals Strategy in 2020, 1 which, in addition to a range of other activities, aims to ensure the regulatory system for human medicines is future? It is too early to say because we have not seen the whole package of measures yet. Future outlook.
Out of trend results What is the origin of out of specification events? The court ruled that any individual OOS event should be investigated, and if a laboratory error cannot be identified, the batch will fail the test. Subscribe What are the typical sources of out of specification events?
The analyst should ensure that the supervisor is notified as soon as an OOS event occurs, the sample is retained, and a documented investigation is commenced. Dealing with out-of-specification results Laboratory result out-of-specification events are a common occurrence in the quality control process.
These may either be specific to the production process itself (such as pyroglutamination of the N-terminus as is frequently seen in monoclonal antibodies (mAbs) or may be the result of purification processes (such as amino acid oxidation or deamidation events) and may indicate that process change is required.
SHOW MORE Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product. Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap.
Out of the 550+ reported counterfeiting incidents, either customs seizures or police/health inspector raids were involved, and 60% of the seizures comprised more than 1,000 dosage units. This amounts to more than 300,000 doses of counterfeit drugs intercepted. kristine.gates… Wed, 06/14/2023 - 08:16 Supply Chain
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content